Aipeng Medical Invests in Beijing Zhiran Medical, Which Launches China's First 100+ Channel Invasive Brain-Computer Interface Clinical Trial

Source: Securities Times

People's Finance News, May 20th, by reporterApon MedicalOn May 18, the first prospective, multi-center clinical trial (LEAP study) of an over 100-channel invasive brain-computer interface system in China was officially launched at Beijing Tiantan Hospital, Capital Medical University. The study is led by Beijing Tiantan Hospital, Capital Medical University, and initiated by Beijing Bciflex Medical Technology Co., Ltd., marking a new phase in the clinical translation of China's independently developed high-throughput invasive brain-computer interface technology.

Jiangsu Apon Medical Technology Co., Ltd. has collaborated with Sequoia Capital China member Xiamen Sequoia Kunteng Investment Partnership through a fund it participated in establishing. Via Beijing Jingjia Management Consulting Center, it has invested in Beijing Bciflex Medical Technology Co., Ltd., actively supporting the innovative development of invasive brain-computer interface frontier technologies and promoting the accelerated layout and improvement of the industrial ecosystem.